Saba Capital Management L.P. Sells 32,108 Shares of Pediatrix Medical Group, Inc. (NYSE:MD)

Saba Capital Management L.P. reduced its stake in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 17.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 147,590 shares of the company's stock after selling 32,108 shares during the quarter. Saba Capital Management L.P. owned approximately 0.17% of Pediatrix Medical Group worth $1,936,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Nomura Asset Management Co. Ltd. boosted its position in Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after purchasing an additional 1,220 shares during the last quarter. Parkside Financial Bank & Trust raised its stake in shares of Pediatrix Medical Group by 36.1% during the 4th quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after purchasing an additional 1,040 shares during the period. AlphaQuest LLC raised its stake in shares of Pediatrix Medical Group by 65.9% during the 4th quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after purchasing an additional 2,012 shares during the period. Smartleaf Asset Management LLC boosted its holdings in shares of Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company's stock worth $91,000 after buying an additional 6,090 shares during the last quarter. Finally, Tower Research Capital LLC TRC grew its position in Pediatrix Medical Group by 218.0% during the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock valued at $98,000 after buying an additional 5,104 shares during the period. 97.71% of the stock is owned by hedge funds and other institutional investors.

Pediatrix Medical Group Stock Performance

Shares of NYSE MD traded up $0.28 during mid-day trading on Tuesday, hitting $15.15. The company had a trading volume of 1,189,925 shares, compared to its average volume of 851,396. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. Pediatrix Medical Group, Inc. has a 1 year low of $6.62 and a 1 year high of $17.67. The company has a market capitalization of $1.30 billion, a price-to-earnings ratio of -12.62, a P/E/G ratio of 1.74 and a beta of 1.26. The stock's 50-day moving average price is $13.75 and its 200-day moving average price is $14.12.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its earnings results on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, topping the consensus estimate of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $458.36 million during the quarter, compared to the consensus estimate of $451.44 million. During the same quarter last year, the company earned $0.20 EPS. The firm's revenue was down 7.4% compared to the same quarter last year. On average, sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analyst Ratings Changes

MD has been the topic of several research reports. UBS Group lowered their price objective on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating on the stock in a research report on Monday, May 12th. StockNews.com upgraded Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research note on Wednesday, January 22nd. Truist Financial decreased their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research report on Friday, April 11th. Finally, Macquarie increased their price target on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a research note on Thursday, May 8th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $16.67.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.